Home | Contact | Imprint

Company Biosimilars Jobs and careers Press Releases Links Contact Imprint		Welcome to Merckle Biotec GmbH     16 September 2008: Biosimilar Ratiograstim® receives EMEA approval First biosimilar for the treatment of neutropenia - Today ratiopharm received from the EMEA the approval for the first Filgrastim biosimilar. Launch will be in the fourth quater of 2008. more... Biosimilars: Turning visions into reality   Merckle Biotec GmbH was founded in 2004 as a wholly-owned subsidiary of Merckle GmbH. Within the ratiopharm group, Merckle Biotec is responsible for producing active biopharmaceutical ingredients and finished dosage forms. more... 2004: Founding of Merckle Biotec GmbH   The founding of Merckle Biotec GmbH with investments in biotech multipurpose plants and further investments in the field of pharmaceutical dosage forms represents a complete value-added chain and related expertise within the ratiopharm group. For more on our company history click on more...		Internal Link     We are putting together a winning team. Are you interested in joining us? Apply now! Here's how to find us. Click here for a map with directions.      Links     Good neighbors: Donautal in Ulm is also where the Merckle parent company headquarters are located.